Regulation & law · 21/12/2012Updated: 10/17/2026 · 1 min read
AMRI Rensselaer, Inc. Files Notice of Registration for Controlled Substance
Summary
AMRI Rensselaer, Inc. has submitted a notice of registration with the U.S. Drug Enforcement Administration (DEA) for a controlled substance, as required by law.
Original source language: Federal Register — Justice DepartmentOpen original release →